1
Total Mentions
1
Documents
0
Connected Entities
Organization referenced in documents
HOUSE_OVERSIGHT_024003_sub_001 - HOUSE_OVERSIGHT_024102
.1 - 3.68 105.6% Chimerix, Inc. Therapeutics 2011 20.6 27.0 44.9 71.9 3.07 3.50 57.7% Epizyme, Inc. Therapeutics 2013 3.4 6.8 - 6.8 2.03 2.03 1583.0% Glumetrics, Inc. Diagnostics & Infrastructure 2008 10.7 - - - - - NM Intercept Pharmaceuticals, Inc. Therapeutics 2012 10.5 34.1 - 34.1 3.24 3.24 323.6% Kalidex Pharmaceuticals, Inc. Therapeutics
No connected entities